News
Recombinant Proteins Market Recombinant proteins are at the heart of modern biopharmaceutical innovation, enabling breakthroughs in drug d ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its ...
Under the agreement, the two parties will collaborate on research and development, production, clinical trials of new drugs ...
ANN ARBOR, Mich., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig ...
GlobalData on MSN
Osivax initiates vaccination in OVX836 trial for influenza A
The study aims to test the immunogenicity, efficacy, and safety of OVX836 in shielding individuals from influenza infections.
TPD technologies, particularly PROTACs and MGDs, represent a paradigm shift in drug development by completely eliminating ...
Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against ...
News-Medical.Net on MSN
Abselion launches AAVX and AAV9 Total Capsid Quantification Kits
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback